Jackson Hole Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.55M Sell
62,790
-56
-0.1% -$6.46K 1.25% 18
2025
Q4
$6.62M Buy
62,846
+117
+0.2% +$11K 1.13% 23
2025
Q3
$5.26M Buy
62,729
+6,756
+12% +$556K 0.9% 29
2025
Q2
$4.43M Buy
55,973
+3,100
+6% +$246K 0.81% 33
2025
Q1
$4.75M Buy
52,873
+2,111
+4% +$197K 0.94% 26
2024
Q4
$5.05M Buy
50,762
+51
+0.1% +$5.26K 1.02% 23
2024
Q3
$5.76M Sell
50,711
-1,880
-4% -$223K 1.2% 21
2024
Q2
$6.51M Buy
52,591
+2,002
+4% +$258K 1.41% 13
2024
Q1
$6.68M Buy
50,589
+951
+2% +$117K 1.51% 15
2023
Q4
$5.41M Buy
49,638
+1,343
+3% +$139K 1.38% 13
2023
Q3
$4.97M Sell
48,295
-3,794
-7% -$409K 1.45% 13
2023
Q2
$6.01M Sell
52,089
-2,277
-4% -$259K 1.64% 11
2023
Q1
$5.76M Buy
54,366
+822
+2% +$88.7K 1.51% 11
2022
Q4
$5.94M Sell
53,544
-384
-0.7% -$39.3K 1.77% 11
2022
Q3
$4.64M Buy
53,928
+745
+1% +$66.5K 1.43% 13
2022
Q2
$4.85M Sell
53,183
-267
-0.5% -$23.7K 1.52% 13
2022
Q1
$4.39M Buy
53,450
+6,341
+13% +$500K 1.26% 17
2021
Q4
$3.61M Sell
47,109
-325
-0.7% -$25.9K 1.13% 25
2021
Q3
$3.56M Buy
47,434
+1,262
+3% +$96K 1.16% 20
2021
Q2
$3.59M Buy
46,172
+40,832
+765% +$3.04M 1.24% 19
2021
Q1
$393K Sell
5,340
-482
-8% -$35.6K 0.16% 118
2020
Q4
$454K Hold
5,822
0.21% 99
2020
Q3
$461K Hold
5,822
0.24% 80
2020
Q2
$430K Sell
5,822
-124
-2% -$9.34K 0.26% 83
2020
Q1
$437K Hold
5,946
0.33% 74
2019
Q4
$516K Hold
5,946
0.28% 88
2019
Q3
$478K Hold
5,946
0.27% 92
2019
Q2
$476K Buy
5,946
+705
+13% +$54K 0.3% 89
2019
Q1
$416K Sell
5,241
-52
-1% -$3.89K 0.37% 86
2018
Q4
$386K Buy
+5,293
New +$374K 0.41% 77

Other funds holding MRK

Jackson Hole Capital Partners's MRK Position: Q1 2026 in Review

Jackson Hole Capital Partners reduced its Merck (MRK) stake by 0.09% in Q1 2026, selling an estimated $6.46K and leaving 62,790 shares worth $7.55M. The position accounts for 1.25% of the portfolio, ranked #18.

Jackson Hole Capital Partners first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jackson Hole Capital Partners held 62,790 shares of Merck worth $7.55M as of Q1 2026.
  • Jackson Hole Capital Partners sold 56 Merck shares in Q1 2026, an estimated $6.46K.
  • Merck made up 1.25% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #18 holding.
  • Jackson Hole Capital Partners first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.